A Reactivity-Tunable Self-Immolative Design Enables Histone Deacetylase-Targeted Imaging and Prodrug Activation

Angew Chem Int Ed Engl. 2022 Nov 21;61(47):e202203243. doi: 10.1002/anie.202203243. Epub 2022 Oct 25.

Abstract

Histone deacetylase (HDAC)-targeted probes and prodrugs are crucial for cancer theranostics. We developed a self-immolative design that enables in vivo activatable near-infrared fluorescence (NIRF) and photoacoustic (PA) imaging and prodrug release in response to HDAC. This design comprises a phenyl ester linker with tunable reactivity, facilitating efficient release of caged fluorophores/drugs upon deacetylation. We engineered a new fluorophore using a spirocyclic xanthene scaffold with ring-open property, affording NIRF/PA detection with high contrast. We showed that a nitro-substituted self-immolative linker allows sensitive NIRF/PA in vivo imaging of HDAC with minimal interference. A highly efficient prodrug system was further developed for targeted therapy in HDAC-overexpressed triple negative breast tumors in mice. Our study provides a valuable paradigm for HDAC-targeted NIRF/PA imaging and prodrug release in vivo, highlighting its potential for bioimaging and drug development.

Keywords: Fluorescent Probes; Histone Deacetylase; Photoacoustic Imaging; Prodrugs; Targeted Therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diagnostic Imaging
  • Fluorescence
  • Fluorescent Dyes
  • Histone Deacetylases
  • Mice
  • Prodrugs* / pharmacology
  • Prodrugs* / therapeutic use

Substances

  • Prodrugs
  • Histone Deacetylases
  • Fluorescent Dyes